CD44 and breast carcinoma: As shown in Figures 1e and f, the expression of NMI was downregulated in breast cancer mammospheres compared with primary breast cancer (Figure 1e) and NMI was also downregulated in the CD44+CD24− cells compared with the CD44−CD24+ cell populations (Figure 1f).